When psychedelics were first studied more than 50 years ago, researchers noticed that they were useful in helping people explore a greater sense of self. Now, after a half-century hiatus, scientists are studying psychedelics like MDMA, psilocybin, and ketamine as treatment for depression, PTSD, anxiety, and other mental health conditions. So, what promise do they hold as therapeutics? Albert Garcia-Romeu, a researcher at John’s Hopkins University, joins Dr. Sanjay Gupta to talk about how psychedelics can alleviate mental suffering and what the path forward might look like. This episode originally aired on November 8, 2022.
To learn more about how CNN protects listener privacy, visit cnn.com/privacy
Learn more about your ad choices. Visit podcastchoices.com/adchoices
To learn more about how CNN protects listener privacy, visit cnn.com/privacy
Learn more about your ad choices. Visit podcastchoices.com/adchoices
The podcast Chasing Life is embedded on this page from an open RSS feed. All files, descriptions, artwork and other metadata from the RSS-feed is the property of the podcast owner and not affiliated with or validated by Podplay.